Newswise — ROCKVILLE, Md. – February 9, 2022 – The Association for Molecular Pathology (AMP), the premier global, molecular diagnostics professional society, today announced the appointment of Ronald M. Przygodzki, MD as the incoming Editor-in-Chief of The Journal of Molecular Diagnostics (JMD). Barbara Zehnbauer, PhD, who has served with distinction as Editor-in-Chief since January 2015, will retire from the position effective March 1, 2022.
Co-owned with The American Society for Investigative Pathology (ASIP) and published by Elsevier, JMD publishes high-quality original papers on scientific advances in the translation and validation of molecular discoveries in medicine into the clinical diagnostic setting, and the description and application of technological advances in the field of molecular diagnostic medicine. In 2020, JMD earned an Impact Factor of 5.568, and its most recent CiteScore (2020) is 8.0.
Dr. Przygodzki is the Director of Genomic Medicine, Office of Research and Development at the US Department of Veterans Affairs (VA). His previous leadership roles include Director, Biomedical Laboratories R&D at the VA; Chief of Pathology at the Children's National Medical Center; and Associate Director of the Molecular Diagnostics Laboratory at the Armed Forces Institute of Pathology. Since joining AMP in 2006, he has served on multiple AMP Committees (Web Editorial Committee, Annual Meeting Program Committee, Membership Affairs Committee, Joint Journal Oversight Committee, and currently as the Chair of the Publications Committee); and he has also served on the JMD Editorial Board since 2010. In 2020, Dr. Przygodzki received AMP’s Meritorious Service Award, which recognizes AMP members for particularly estimable service to the organization.
“On behalf of AMP and ASIP members, I am honored to congratulate Dr. Przygodzki on his well-deserved appointment to Editor-in-Chief,” said Emily H. Essex, ASIP Director of Scientific Publications. “As a dedicated volunteer, he helped implement impressive changes for The Journal of Molecular Diagnostics, including updating its scope to include clinical informatics, expanding to 12 issues per year (up from six), offering publication discounts, and much more. We look forward to continued excellence for the Journal with Dr. Przygodzki at the helm.”
ABOUT AMP
The Association for Molecular Pathology (AMP) was founded in 1995 to provide structure and leadership to the emerging field of molecular diagnostics. AMP's 2,500+ members practice various disciplines of molecular diagnostics, including bioinformatics, infectious diseases, inherited conditions, and oncology. Our members are pathologists, clinical laboratory directors, basic and translational scientists, technologists, and trainees that practice in a variety of settings, including academic and community medical centers, government, and industry. Through the efforts of its Board of Directors, Committees, Working Groups, and Members, AMP is the primary resource for expertise, education, and collaboration in one of the fastest growing fields in healthcare. AMP members influence policy and regulation on the national and international levels, ultimately serving to advance innovation in the field and protect patient access to high quality, appropriate testing. For more information, visit www.amp.org and follow AMP on Twitter: @AMPath
ABOUT ASIP
The American Society for Investigative Pathology (ASIP ) is a non-profit society for biomedical scientists that promotes the discovery, advancement, and dissemination of basic and translational knowledge in experimental/investigative pathology and related disciplines. Experimental/investigative pathology is an integrative discipline that links the manifestations of disease in the whole organism to its fundamental cellular and molecular mechanisms. It uses a variety of structural, functional, and genetic techniques, and ultimately applies research findings to the characterization, diagnosis, and treatment of diseases. The Society advocates for the practice of experimental/investigative pathology and fosters the professional career development and education of its members. The Society promotes equal representation and opportunity among investigators in experimental/investigative pathology research and related disciplines. These objectives are achieved by fostering investigation into the molecular and cellular pathogenesis, diagnosis and classification, pathophysiology, and prognosis of disease through meetings, scientific publications, educational activities, career development events, activities, and other research proceedings. For more information visit https://www.asip.org/ or follow ASIP on social media @ASIPathology (Facebook) or @ASIPath (Twitter).
###
RSS